Presentation_outline

.docx

School

University of Illinois, Chicago *

*We aren’t endorsed by this school

Course

319

Subject

Health Science

Date

Dec 6, 2023

Type

docx

Pages

Uploaded by ChiefKangarooMaster696

Presentation outline Topic- Lower Drug Prices ❖ Name of Members:- Dimpy Shah Ayesha Khatoon Lanise McGary Iqra Shaf ❖ Info- why and what the prices, comparison to other counties. This includes insurance -ayesha This section will discuss why drug prices are an issue and the causes and effects of this. This slide will provide background information as to why this is a real concern. It will also talk about how America charges for drugs versus other countries. There is a clear difference and opening with this will allow those watching the presentation really understand the issue at hand. Vincent Rajkumar, S. (2020). The high cost of prescription drugs: Causes and solutions. Blood Cancer Journal, 10(6). https://doi.org/10.1038/s41408-020-0338-x ❖ Transparency in increase in prices of drugs such as Insulin: - Drug prices are increasing as time goes by and in the last few years due to inflation, the market is down with no jobs available, and people can’t afford to buy their needed medication. As per the report provided by “JDRF”, “It’s important to know that insurance plans don’t always cover every available insulin, and yours may not be covered. You will need to check the formulary to see whether your insulin is covered and, if so, on which tier.”

Common issues around insulin, insulin pumps, CGMS, and test strips. JDRF. (n.d.). https://www.jdrf.org/t1d-resources/living-with-t1d/insurance/issues- around-insulin-pumps/#:~:text=Insulin%20Issues&text=It%27s %20important%20to%20know%20that,if%20so%2C%20on%20which %20tier ❖ Biosimilar drugs- explores the potential of lower costing similar medicine-Lanise Reference- What are biosimilar drugs?: Biosimilar Drugs for Cancer Treatment. Biosimilar Drugs for Cancer Treatment | American Cancer Society. (n.d.). https://www.cancer.org/cancer/managing-cancer/treatment-types/biosimilar- drugs/what-are-biosimilars.html#:~:text=A%20biosimilar%2C%20or %20biosimilar,can%20work%20in%20many%20ways. ❖ Telemedicine and price control regulation/ availability in the rural areas and bidens new regulations/ Iqra Shaf “Issues under debate by stakeholders include long-term audio-only coverage; broadband connectivity; disparities in access to telehealth; appropriate payment for telehealth versus in-person care; concerns about fraud, quality, and safety; and the need for additional data to inform future policymaking,” M;, S. (n.d.). Regulatory and legislative issues on telehealth . Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition. https://pubmed.ncbi.nlm.nih.gov/34159667/ or

Your preview ends here

Eager to read complete document? Join bartleby learn and gain access to the full version

Access to all documents
Unlimited textbook solutions
24/7 expert homework help